Mark Murphy Fca

Mark Murphy CPA FCA is an experienced finance professional currently serving as VP of Finance at Beacon Therapeutics since 2023. Previously, Mark held the position of US Finance Lead at Novartis from 2019 to 2023, where responsibilities included managing US Finance functions and ensuring accurate financial reporting. With extensive experience at Iroko Pharmaceuticals as Senior Vice President, Finance & Controller and various roles at Shire Pharmaceuticals, FXI, Challenger Limited, Dresdner Bank Latinamerika AG, and PwC Ireland, Mark has demonstrated expertise in financial management, compliance with GAAP, financial planning and analysis, and leadership in financial operations. Mark holds a CPA certification and degrees in Accounting from Chartered Accountants Ireland and a Master's degree from University College Dublin.